Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based Methods.
Kunst N, Wilson ECF, Glynn D, Alarid-Escudero F, Baio G, Brennan A, Fairley M, Goldhaber-Fiebert JD, Jackson C, Jalal H, Menzies NA, Strong M, Thom H, Heath A; Collaborative Network for Value of Information. Kunst N, et al. Value Health. 2020 Jun;23(6):734-742. doi: 10.1016/j.jval.2020.02.010. Epub 2020 May 27. Value Health. 2020. PMID: 32540231 Free PMC article.
Perspective and Costing in Cost-Effectiveness Analysis, 1974-2018.
Kim DD, Silver MC, Kunst N, Cohen JT, Ollendorf DA, Neumann PJ. Kim DD, et al. Among authors: kunst n. Pharmacoeconomics. 2020 Oct;38(10):1135-1145. doi: 10.1007/s40273-020-00942-2. Pharmacoeconomics. 2020. PMID: 32696192 Free PMC article.
Breast Cancer Screening and Health Care Costs-Reply.
Kunst N, Gross CP. Kunst N, et al. JAMA Intern Med. 2020 Nov 1;180(11):1553-1554. doi: 10.1001/jamainternmed.2020.2355. JAMA Intern Med. 2020. PMID: 32777026 No abstract available.
Early Cost-effectiveness Analysis of Risk-Based Selection Strategies for Adjuvant Treatment in Stage II Colon Cancer: The Potential Value of Prognostic Molecular Markers.
Jongeneel G, Greuter MJE, Kunst N, van Erning FN, Koopman M, Medema JP, Vermeulen L, Ijzermans JNM, Vink GR, Punt CJA, Coupé VMH. Jongeneel G, et al. Among authors: kunst n. Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1726-1734. doi: 10.1158/1055-9965.EPI-21-0078. Epub 2021 Jun 23. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 34162659 Free PMC article.
35 results